Rheumatoid arthritis is still expensive in the new decade: a comparison between two early RA cohorts, diagnosed 1996–98 and 2006–09

Direct Health Costs of Inflammatory Polyarthritis 10 Years after Disease Onset: Results from the Norfolk Arthritis Register

(2015) E. Nikiphorou et al.   JOURNAL OF RHEUMATOLOGY

Factors influencing rheumatologists’ prescription of biological treatment in rheumatoid arthritis: an interview study

(2014) Almina Kalkan et al.   Implementation Science

Work Productivity Loss in Early Arthritis During the First 3 Years of Disease: A Study From a French National Multicenter Cohort

(2014) Sabrina Dadoun et al.   ARTHRITIS CARE & RESEARCH

Hand and Foot Surgery Rates in Rheumatoid Arthritis Have Declined From 1986 to 2011, but Large-Joint Replacement Rates Remain Unchanged: Results From Two UK Inception Cohorts

(2014) Elena Nikiphorou et al.   Arthritis & Rheumatology

Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial

(2013) Vappu Rantalaiho et al.   ANNALS OF THE RHEUMATIC DISEASES

Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010

(2013) Anna-Birgitte Aga et al.   ANNALS OF THE RHEUMATIC DISEASES

Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?

(2013) Jonas K Eriksson et al.   ANNALS OF THE RHEUMATIC DISEASES

Costs of rheumatoid arthritis during the period 1990-2010: a register-based cost-of-illness study in Sweden

(2013) A. Kalkan et al.   RHEUMATOLOGY

Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA project

(2013) E Hallert et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Consequences of inflammatory arthritis for workplace productivity loss and sick leave: a systematic review

(2012) Marie-Louise B Lenssinck et al.   ANNALS OF THE RHEUMATIC DISEASES

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial

(2012) Ronald F van Vollenhoven et al.   LANCET

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

(2012) Jasvinder A. Singh et al.   ARTHRITIS CARE & RESEARCH

How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?

(2011) M. Neovius et al.   ANNALS OF THE RHEUMATIC DISEASES

Decrease in the incidence of total hip arthroplasties in patients with rheumatoid arthritis - results from a well defined population in south Sweden

(2011) Korosh Hekmat et al.   ARTHRITIS RESEARCH & THERAPY

Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden

(2010) M. Neovius et al.   ANNALS OF THE RHEUMATIC DISEASES

Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

(2010) S. L. Gorter et al.   ANNALS OF THE RHEUMATIC DISEASES

Cost of illness in rheumatoid arthritis in Germany in 1997-98 and 2002: cost drivers and cost savings

(2010) T. Kirchhoff et al.   RHEUMATOLOGY

Rapid and sustained health utility gain in anti-tumour necrosis factor-treated inflammatory arthritis: observational data during 7 years in southern Sweden

(2009) A Gulfe et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis

(2009) Arthur Kavanaugh et al.   ARTHRITIS AND RHEUMATISM

Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature

(2008) K Visser et al.   ANNALS OF THE RHEUMATIC DISEASES